Sonoma Pharmaceuticals, Inc. (SNOA)

Sonoma Pharmaceuticals Revenue

Sonoma Pharmaceuticals had revenue of $3.56M in the quarter ending December 31, 2024, with 13.58% growth. This brings the company's revenue in the last twelve months to $13.97M, up 13.51% year-over-year. In the fiscal year ending March 31, 2024, Sonoma Pharmaceuticals had annual revenue of $12.74M, down -4.05%.

• Revenue (ttm): $13.97M
• Revenue Growth: +13.51%
• P/S Ratio: 0.18
• Revenue / Employee: $1,397,300
• Employees: 10
• Market Cap: 3.87M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	12.74M	-537.00K	-4.05%
Mar 31, 2023	13.27M	644.00K	5.10%
Mar 31, 2022	12.63M	-6.00M	-32.21%
Mar 31, 2021	18.63M	701.00K	3.91%
Mar 31, 2020	17.93M	-1.04M	-5.49%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.